List of Tables
Table 1. Global Protein Degradation Targeting Chimera (PROTAC) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Protein Degradation Targeting Chimera (PROTAC) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Protein Degradation Targeting Chimera (PROTAC) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Protein Degradation Targeting Chimera (PROTAC) Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Protein Degradation Targeting Chimera (PROTAC) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Protein Degradation Targeting Chimera (PROTAC) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Protein Degradation Targeting Chimera (PROTAC), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Protein Degradation Targeting Chimera (PROTAC), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Protein Degradation Targeting Chimera (PROTAC), Product Types and Applications
Table 12. Global Key Manufacturers of Protein Degradation Targeting Chimera (PROTAC), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Protein Degradation Targeting Chimera (PROTAC) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Protein Degradation Targeting Chimera (PROTAC) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Protein Degradation Targeting Chimera (PROTAC) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Protein Degradation Targeting Chimera (PROTAC) Sales by Region (K Units), 2021–2026
Table 18. Global Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Region (2021–2026)
Table 19. Global Protein Degradation Targeting Chimera (PROTAC) Sales by Region (K Units), 2027–2032
Table 20. Global Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Region (2027–2032)
Table 21. Global Protein Degradation Targeting Chimera (PROTAC) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Region (2021–2026)
Table 23. Global Protein Degradation Targeting Chimera (PROTAC) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Region (2027–2032)
Table 25. North America Protein Degradation Targeting Chimera (PROTAC) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2021–2026
Table 27. North America Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2027–2032
Table 28. North America Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Protein Degradation Targeting Chimera (PROTAC) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2021–2026
Table 32. Europe Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2027–2032
Table 33. Europe Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Protein Degradation Targeting Chimera (PROTAC) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Protein Degradation Targeting Chimera (PROTAC) Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Protein Degradation Targeting Chimera (PROTAC) Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Protein Degradation Targeting Chimera (PROTAC) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Protein Degradation Targeting Chimera (PROTAC) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Protein Degradation Targeting Chimera (PROTAC) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2021–2026
Table 42. Latin America Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2027–2032
Table 43. Latin America Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Protein Degradation Targeting Chimera (PROTAC) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Protein Degradation Targeting Chimera (PROTAC) Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Protein Degradation Targeting Chimera (PROTAC) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Protein Degradation Targeting Chimera (PROTAC) Sales (K Units) by Type (2021–2026)
Table 51. Global Protein Degradation Targeting Chimera (PROTAC) Sales (K Units) by Type (2027–2032)
Table 52. Global Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Type (2021–2026)
Table 53. Global Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Type (2027–2032)
Table 54. Global Protein Degradation Targeting Chimera (PROTAC) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Protein Degradation Targeting Chimera (PROTAC) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Type (2021–2026)
Table 57. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Type (2027–2032)
Table 58. Global Protein Degradation Targeting Chimera (PROTAC) Price (US$/Unit) by Type (2021–2026)
Table 59. Global Protein Degradation Targeting Chimera (PROTAC) Price (US$/Unit) by Type (2027–2032)
Table 60. Global Protein Degradation Targeting Chimera (PROTAC) Sales (K Units) by Application (2021–2026)
Table 61. Global Protein Degradation Targeting Chimera (PROTAC) Sales (K Units) by Application (2027–2032)
Table 62. Global Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Application (2021–2026)
Table 63. Global Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Application (2027–2032)
Table 64. Global Protein Degradation Targeting Chimera (PROTAC) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Protein Degradation Targeting Chimera (PROTAC) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Application (2021–2026)
Table 67. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Application (2027–2032)
Table 68. Global Protein Degradation Targeting Chimera (PROTAC) Price (US$/Unit) by Application (2021–2026)
Table 69. Global Protein Degradation Targeting Chimera (PROTAC) Price (US$/Unit) by Application (2027–2032)
Table 70. Arvinas Company Information
Table 71. Arvinas Description and Business Overview
Table 72. Arvinas Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Arvinas Protein Degradation Targeting Chimera (PROTAC) Product
Table 74. Arvinas Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Protein Degradation Targeting Chimera (PROTAC) Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Kymera Company Information
Table 81. Kymera Description and Business Overview
Table 82. Kymera Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Kymera Protein Degradation Targeting Chimera (PROTAC) Product
Table 84. Kymera Recent Developments/Updates
Table 85. Nurix Company Information
Table 86. Nurix Description and Business Overview
Table 87. Nurix Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Nurix Protein Degradation Targeting Chimera (PROTAC) Product
Table 89. Nurix Recent Developments/Updates
Table 90. C4 Therapeutics, Inc. Company Information
Table 91. C4 Therapeutics, Inc. Description and Business Overview
Table 92. C4 Therapeutics, Inc. Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. C4 Therapeutics, Inc. Protein Degradation Targeting Chimera (PROTAC) Product
Table 94. C4 Therapeutics, Inc. Recent Developments/Updates
Table 95. Astellas Pharma Inc. Company Information
Table 96. Astellas Pharma Inc. Description and Business Overview
Table 97. Astellas Pharma Inc. Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Astellas Pharma Inc. Protein Degradation Targeting Chimera (PROTAC) Product
Table 99. Astellas Pharma Inc. Recent Developments/Updates
Table 100. AbbVie Company Information
Table 101. AbbVie Description and Business Overview
Table 102. AbbVie Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AbbVie Protein Degradation Targeting Chimera (PROTAC) Product
Table 104. AbbVie Recent Developments/Updates
Table 105. Captor therapeutics Company Information
Table 106. Captor therapeutics Description and Business Overview
Table 107. Captor therapeutics Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Captor therapeutics Protein Degradation Targeting Chimera (PROTAC) Product
Table 109. Captor therapeutics Recent Developments/Updates
Table 110. Amgen Company Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Amgen Protein Degradation Targeting Chimera (PROTAC) Product
Table 114. Amgen Recent Developments/Updates
Table 115. Oerth Bio Company Information
Table 116. Oerth Bio Description and Business Overview
Table 117. Oerth Bio Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Oerth Bio Protein Degradation Targeting Chimera (PROTAC) Product
Table 119. Oerth Bio Recent Developments/Updates
Table 120. Bayer Company Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Bayer Protein Degradation Targeting Chimera (PROTAC) Product
Table 124. Bayer Recent Developments/Updates
Table 125. Kaituo Pharmaceutical Company Information
Table 126. Kaituo Pharmaceutical Description and Business Overview
Table 127. Kaituo Pharmaceutical Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Kaituo Pharmaceutical Protein Degradation Targeting Chimera (PROTAC) Product
Table 129. Kaituo Pharmaceutical Recent Developments/Updates
Table 130. Haichuang Pharmaceutical Company Information
Table 131. Haichuang Pharmaceutical Description and Business Overview
Table 132. Haichuang Pharmaceutical Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Haichuang Pharmaceutical Protein Degradation Targeting Chimera (PROTAC) Product
Table 134. Haichuang Pharmaceutical Recent Developments/Updates
Table 135. Betta Pharmaceuticals Company Information
Table 136. Betta Pharmaceuticals Description and Business Overview
Table 137. Betta Pharmaceuticals Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Betta Pharmaceuticals Protein Degradation Targeting Chimera (PROTAC) Product
Table 139. Betta Pharmaceuticals Recent Developments/Updates
Table 140. BeiGene Company Information
Table 141. BeiGene Description and Business Overview
Table 142. BeiGene Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. BeiGene Protein Degradation Targeting Chimera (PROTAC) Product
Table 144. BeiGene Recent Developments/Updates
Table 145. East China Pharmaceutical Group Company Information
Table 146. East China Pharmaceutical Group Description and Business Overview
Table 147. East China Pharmaceutical Group Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. East China Pharmaceutical Group Protein Degradation Targeting Chimera (PROTAC) Product
Table 149. East China Pharmaceutical Group Recent Developments/Updates
Table 150. Hengrui Medicine Company Information
Table 151. Hengrui Medicine Description and Business Overview
Table 152. Hengrui Medicine Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Hengrui Medicine Protein Degradation Targeting Chimera (PROTAC) Product
Table 154. Hengrui Medicine Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Protein Degradation Targeting Chimera (PROTAC) Distributors List
Table 158. Protein Degradation Targeting Chimera (PROTAC) Customers List
Table 159. Protein Degradation Targeting Chimera (PROTAC) Market Trends
Table 160. Protein Degradation Targeting Chimera (PROTAC) Market Drivers
Table 161. Protein Degradation Targeting Chimera (PROTAC) Market Challenges
Table 162. Protein Degradation Targeting Chimera (PROTAC) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Protein Degradation Targeting Chimera (PROTAC)
Figure 2. Global Protein Degradation Targeting Chimera (PROTAC) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Protein Degradation Targeting Chimera (PROTAC) Market Share by Type: 2025 & 2032
Figure 4. Based on CRBN Product Picture
Figure 5. Based on VHL Product Picture
Figure 6. Global Protein Degradation Targeting Chimera (PROTAC) Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Protein Degradation Targeting Chimera (PROTAC) Market Share by Application: 2025 & 2032
Figure 8. Breast Cancer
Figure 9. Prostate Cancer
Figure 10. Colorectal Cancer
Figure 11. Pancreatic Cancer
Figure 12. Lymphoma
Figure 13. Androgenic Alopecia
Figure 14. Others
Figure 15. Global Protein Degradation Targeting Chimera (PROTAC) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Protein Degradation Targeting Chimera (PROTAC) Market Size (US$ Million), 2021–2032
Figure 17. Global Protein Degradation Targeting Chimera (PROTAC) Sales (K Units), 2021–2032
Figure 18. Global Protein Degradation Targeting Chimera (PROTAC) Average Price (US$/Unit), 2021–2032
Figure 19. Protein Degradation Targeting Chimera (PROTAC) Report Years Considered
Figure 20. Protein Degradation Targeting Chimera (PROTAC) Sales Share by Manufacturers in 2025
Figure 21. Global Protein Degradation Targeting Chimera (PROTAC) Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Protein Degradation Targeting Chimera (PROTAC) Players: Market Share by Revenue in Protein Degradation Targeting Chimera (PROTAC) in 2025
Figure 23. Protein Degradation Targeting Chimera (PROTAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Protein Degradation Targeting Chimera (PROTAC) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Country (2021–2032)
Figure 26. North America Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Country (2021–2032)
Figure 27. United States Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Country (2021–2032)
Figure 30. Europe Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Country (2021–2032)
Figure 31. Germany Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Region (2021–2032)
Figure 38. China Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Country (2021–2032)
Figure 46. Latin America Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Protein Degradation Targeting Chimera (PROTAC) Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Protein Degradation Targeting Chimera (PROTAC) Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Protein Degradation Targeting Chimera (PROTAC) Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Protein Degradation Targeting Chimera (PROTAC) by Type (2021–2032)
Figure 57. Global Revenue Market Share of Protein Degradation Targeting Chimera (PROTAC) by Type (2021–2032)
Figure 58. Global Protein Degradation Targeting Chimera (PROTAC) Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Protein Degradation Targeting Chimera (PROTAC) by Application (2021–2032)
Figure 60. Global Revenue Market Share of Protein Degradation Targeting Chimera (PROTAC) by Application (2021–2032)
Figure 61. Global Protein Degradation Targeting Chimera (PROTAC) Price (US$/Unit) by Application (2021–2032)
Figure 62. Protein Degradation Targeting Chimera (PROTAC) Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
